regulatory approval

NICE Approves Takeda's Exkivity for EGFR Exon 20 Insertion-Positive NSCLC

FDA Approves ImmunoGen's Elahere for Folate Receptor Alpha-Positive Ovarian Cancer

BMS Combo Immunotherapy Opdualag Approved in Europe for Biomarker-Defined Melanoma Patients

Pillar Biosciences Receives China Approval for Colon Cancer Companion Diagnostic Assay

FDA Approves Enhertu for HER2-Low Metastatic Breast Cancer

Pfizer's Xalkori Gets FDA Approval for ALK-Positive Inflammatory Myofibroblastic Tumors

European Commission Approves Novartis MET Inhibitor Tabrecta for Advanced NSCLC

NICE Recommends AstraZeneca's Imfinzi for PD-L1-Positive NSCLC

Bristol Myers Squibb's Breyanzi Approved in Europe for Lymphoma Patients

Xcovery's Ensartinib Approved for First-Line ALK-Positive NSCLC in China

Burning Rock Secures Lung Cancer NGS Test Regulatory Approval in China

Pfizer's Lorviqua Approved in EU for First-Line Treatment of ALK-Positive Advanced Lung Cancer

FDA Approves Immunocore's T-Cell Receptor Therapy Kimmtrak for Uveal Melanoma Patients

CStone, Blueprint Medicines' Ayvakit Nets Hong Kong Approval for Biomarker-Defined GIST

European Commission Approves Roche's Gavreto for RET Fusion-Positive NSCLC

European Commission Approves Merck's Keytruda-Chemo Combination for Advanced TNBC Patients

FDA Approves Gilead's Tecartus for Acute Lymphoblastic Leukemia

Pillar Biosciences Receives FDA Approval for OncoReveal Dx Lung and Colon Cancer Assay

NICE Recommends Incyte's Pemazyre for FGFR2-Positive Bile Duct Cancer